A novel 1-benzoazepine-derived Michael acceptor and its hetero-adducts active against MRSA
Language English Country Great Britain, England Media electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
39480656
DOI
10.1039/d4ob01501k
Knihovny.cz E-resources
- MeSH
- Anti-Bacterial Agents * pharmacology chemistry chemical synthesis MeSH
- Azepines pharmacology chemistry chemical synthesis MeSH
- Chlorocebus aethiops MeSH
- Humans MeSH
- Methicillin-Resistant Staphylococcus aureus * drug effects MeSH
- Microbial Sensitivity Tests * MeSH
- Molecular Structure MeSH
- Vero Cells MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Anti-Bacterial Agents * MeSH
- Azepines MeSH
Multidrug-resistant bacterial infections continue to be a rising global health concern. Herein, we describe the development of a novel class of 3-substituted benzoazepinedione derivatives with promising antibacterial activity. The pivotal compound, benzoazepinedione carboxylate 9, represents a highly electrophilic Michael acceptor, enabling divergent access to a wide range of thia-, aza-, oxa-, and phospha-Michael adducts. Notably, most prepared compounds exhibited potent antibacterial activity against both drug-susceptible and drug-resistant strains of Staphylococcus aureus (MIC90 of up to 2 μg mL-1). The cytotoxicity assessment in the VERO6 cell line revealed that thia-adduct 10d (IC50 of 36.5 μg mL-1) exhibits lower toxicity compared to its parent electrophile 9 (IC50 of 14.3 μg mL-1), which is in agreement with the hypothesis of covalently modified prodrugs. Additionally, stability studies of the prepared compounds in CD3OD and a DMSO-PBS mixture confirmed that thia-Michael adducts 10 are stable under neutral conditions while dynamic under mildly basic conditions. Moreover, 3D reconstructed tissue models (human lung epithelial EpiAirway™ and a human small intestine model) did not exhibit a viability decrease below 80% of the untreated control at all concentrations tested, indicating tolerance to higher concentrations of potential drugs and prodrugs.
Central Laboratories Slovak University of Technology Radlinského 9 812 37 Bratislava Slovakia
Department of Chemistry Faculty of Education Trnava University Priemyselná 4 918 43 Trnava Slovakia
References provided by Crossref.org